• Formoterol is a long-acting β2 agonist (LABA) indicated in asthma (including nocturnal asthma and exercise-induced symptoms) for those treated with inhaled corticosteroids who also require a long-acting beta agonist in accordance with current treatment guidelines.
  • Formoterol is indicated for the relief of reversible airways obstruction in patients with chronic obstructive pulmonary disease (COPD) requiring long-term bronchodilatory therapy.
  • Our product contains 12 µg of formoterol as inhalation powder in HPMC capsules to be used with the Axahaler® DPI device. Our unique and patented technology provides enhanced stability to our product.
  • Clinical Studies: pharmacokinetic  and pharmacodynamic  studies vs. originator.